Medtronic stock trades at USD 88.51 after Q1 growth

Published on 09/25/2026 at 13:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medtronic stock posted USD 9.756 billion in Q1 fiscal 2027 revenue on September 1, 2026, up 13.7 percent year over year. Fiscal guidance also increased.

Reinraumfertigung mit Technikern bei Montage medizintechnischer Präzisionsinstrumente — Medtronic plc (ISIN IE00BTN1Y115) Reinraum-Fertigung zeigt Techniker bei der Montage medizinischer Präzisionsinstrumente sorgfältig, Illustration mit AI erstellt.

Medtronic plc (ISIN IE00BTN1Y115) stood at USD 88.51 on the NYSE on September 24, 2026, down 0.88 percent from the prior session. The medical-device maker's first-quarter fiscal 2027 revenue reached USD 9.756 billion, giving investors a sharper test of its upgraded outlook.

Revenue growth resets expectations

According to Medtronic on September 1, 2026, Q1 fiscal 2027 revenue increased 13.7 percent from the year-earlier period ended July 31, 2026. GAAP diluted EPS was USD 1.14, while non-GAAP diluted EPS reached USD 1.45.

The earnings mix also improved. GAAP operating profit rose 22.1 percent to USD 1.764 billion, and the GAAP operating margin reached 18.1 percent versus 16.8 percent in Q1 fiscal 2026, a 1.2 percentage-point increase, according to Medtronic.

Guidance moves higher

Medtronic lifted fiscal 2027 organic revenue growth guidance to 7.25 percent to 7.75 percent from 6.75 percent to 7.25 percent. Its diluted non-GAAP EPS outlook increased to USD 5.94 to USD 6.00 from USD 5.90 to USD 6.00.

The earnings beat was measurable against consensus. Investing.com reported adjusted EPS of USD 1.45 versus the USD 1.39 estimate, while revenue of USD 9.8 billion exceeded the USD 9.55 billion forecast. The revenue comparison represents a USD 250 million beat.

Analyst target points higher

On September 2, 2026, Mizuho raised its Medtronic price target to USD 115 from USD 100 and maintained an Outperform rating, citing cardiovascular products and new product launches, as Investing.com reported. The revised target is USD 26.49, or 29.9 percent, above the September 24 price.

Stock remains below yearly high

Medtronic's reference price of USD 88.51 was 16.8 percent below its 52-week high of USD 106.33 and 20.7 percent above its 52-week low of USD 73.31 on September 24, 2026. Market capitalization stood at USD 113,297,225,500, with volume of 10,956,323 shares.